Estradiol treatment prevents injury induced enhancement in spinal cord dynorphin expression

Frontiers in Physiology

Volumn 3 FEB, Issue , 2012, Pages

  Gupta, Daya S ^a   Hubscher, Charles H ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Dynorphin; Estradiol; Neuropathic pain; Spinal cord injury

Indexed keywords

EID: 84866266792     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00028     Document Type: Article

References (78)

1. Abraham, K. E., McGinty, J. F., and Brewer, K. L. (2001). Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury. Pain 90, 181-190.
2. Appleyard, S. M., Patterson, T. A., Jin, W., and Chavkin, C. (1997). Agonistinduced phosphorylation of the kappa-opioid receptor. J. Neurochem. 69, 2405-2412.
3. Bagatell, C. J., Dahl, K. D., and Bremner, W. J. (1994). The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. J. Androl. 15, 15-21.
4. Botticelli, L. J., Cox, B. M., and Goldstein, A. (1981). Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proc. Natl. Acad. Sci. U.S.A. 78, 7783-7786.
5. Calza, L., Pozza, M., Zanni, M., Manzini, C. U., Manzini, E., and Hokfelt, T. (1998). Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study. Neuroscience 82, 575-589.
6. Carlton, S. M., Du, J., Tan, H. Y., Nesic, O., Hargett, G. L., Bopp, A. C., Yamani, A., Lin, Q., Willis, W. D., and Hulsebosch, C. E. (2009). Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury. Pain 147, 265-276.
7. Chaovipoch, P., Jelks, K. A., Gerhold, L. M., West, E. J., Chongthammakun, S., and Floyd, C. L. (2006). 17betaestradiol is protective in spinal cord injury in postand pre-menopausal rats. J. Neurotrauma 23, 830-852.
8. Chen, Y., Chen, C., and Liu-Chen, L. Y. (2007). Dynorphin peptides differentially regulate the human kappa opioid receptor. Life Sci. 80, 1439-1448.
9. Cho, H. J., and Basbaum, A. I. (1989). Ultrastructural analysis of dynorphin B-immunoreactive cells and terminals in the superficial dorsal horn of the deafferented spinal cord of the rat. J. Comp. Neurol. 281, 193-205.
10. Cothron, K. J., Massey, J. M., Onifer, S. M., and Hubscher, C. H. (2008). Identification of penile inputs to the rat gracile nucleus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1015-R1023.
11. Crown, E. D., Gwak, Y. S., Ye, Z., Johnson, K. M., and Hulsebosch, C. E. (2008). Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury. Exp. Neurol. 213, 257-267.
12. Dantas, A. P., Tostes, R. C., Fortes, Z. B., Costa, S. G., Nigro, D., and Carvalho, M. H. (2002). In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 39, 405-411.
13. De Camilli, P., Cameron, R., and Greengard, P. (1983). Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunofluorescence in frozen and plastic sections. J. Cell Biol. 96, 1337-1354.
14. de Groat, W. C. (1998). Anatomy of the central neural pathways controlling the lower urinary tract. Eur. Urol. 34(Suppl. 1), 2-5.
15. Diamond, B., and Yelton, D. E. (1981). A new Fc receptor on mouse macrophages binding IgG3. J. Exp. Med. 153, 514-519.
16. Dogra, C., Changotra, H., Wergedal, J. E., and Kumar, A. (2006). Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch. J. Cell. Physiol. 208, 575-585.
17. Echeverry, S., Shi, X. Q., and Zhang, J. (2008). Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 135, 37-47.
18. Faden, A. I., Molineaux, C. J., Rosenberger, J. G., Jacobs, T. P., and Cox, B. M. (1985). Increased dynorphin immunoreactivity in spinal cord after traumatic injury. Regul. Pept. 11, 35-41.
19. Fremeau, R. T. Jr., Voglmaier, S., Seal, R. P., and Edwards, R. H. (2004). VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci. 27, 98-103.
20. Gintzler, A. R., Schnell, S. A., Gupta, D. S., Liu, N. J., and Wessendorf, M. W. (2008). Relationship of spinal dynorphin neurons to delta-opioid receptors and estrogen receptor alpha: anatomical basis for ovarian sex steroid opioid antinociception. J. Pharmacol. Exp. Ther. 326, 725-731.
21. Goldstein, A., and Ghazarossian, V. E. (1980). Immunoreactive dynorphin in pituitary and brain. Proc. Natl. Acad. Sci. U.S.A. 77, 6207-6210.
22. Gottsch, M. L., Navarro, V. M., Zhao, Z., Glidewell-Kenney, C., Weiss, J., Jameson, J. L., Clifton, D. K., Levine, J. E., and Steiner, R. A. (2009). Regulation of Kiss1 and dynorphin gene expression in the murine brain by classical and nonclassical estrogen receptor pathways. J. Neurosci. 29, 9390-9395.
23. Guillery, R. W. (2000). Early electron microscopic observations of synaptic structures in the cerebral cortex: a view of the contributions made by George Gray (1924-1999). Trends Neurosci. 23, 594-598.
24. Hall, B. J., Lally, J. E., Vukmanic, E. V., Armstrong, J. E., Fell, J. D., Gupta, D. S., and Hubscher, C. H. (2010). Spinal cord injuries containing asymmetrical damage in the ventrolateral funiculus is associated with a higher incidence of at-level allodynia. J. Pain. 11, 864-875.
25. Honore, P., Rogers, S. D, Schwei, M. J., Salak-Johnson, J. L., Luger, N. M., Sabino, M. C., Clohisy, D. R., and Mantyh, P. W. (2000). Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 98, 585-598.
26. Hubscher, C. H., Fell, J. D., and Gupta, D. S. (2010). Sex and hormonal variations in the development of at-level allodynia in a rat chronic spinal cord injury model. Neurosci. Lett. 477, 153-156.
27. Hubscher, C. H., and Johnson, R. D. (1999). Changes in neuronal receptive field characteristics in caudal brain stem following chronic spinal cord injury. J. Neurotrauma 16, 533-541.
28. Hubscher, C. H., and Johnson, R. D. (2006). Chronic spinal cord injury induced changes in the responses of thalamic neurons. Exp. Neurol. 197, 177-188.
29. Hubscher, C. H., Kaddumi, E. G., and Johnson, R. D. (2008). Segmental neuropathic pain does not develop in male rats with complete spinal transections. J. Neurotrauma 25, 1241-1245.
30. Jansen, A. S., Farwell, D. G., and Loewy, A. D. (1993). Specificity of pseudorabies virus as a retrograde marker of sympathetic preganglionic neurons: implications for transneuronal labeling studies. Brain Res. 617, 103-112.
31. Jiao, Y., Sun, Z., Lee, T., Fusco, F. R., Kimble, T. D., Meade, C. A., Cuthbertson, S., and Reiner, A. (1999). A simple and sensitive antigen retrieval method for free-floating and slidemounted tissue sections. J. Neurosci. Methods 93, 149-162.
32. Kachadroka, S., Hall, A. M., Niedzielko, T. L., Chongthammakun, S., and Floyd, C. L. (2010). Effect of endogenous androgens on 17betaestradiol-mediated protection after spinal cord injury in male rats. J. Neurotrauma 27, 611-626.
33. Kalra, S. P., and Kalra, P. S. (1974). Temporal interrelationships among circulating levels of estradiol, progesterone and LH during the rat estrous cycle: effects of exogenous progesterone. Endocrinology 95, 1711-1718.
34. Kramer, P. R., and Bellinger, L. L. (2009). The effects of cycling levels of 17beta-estradiol and progesterone on the magnitude of temporomandibular joint-induced nociception. Endocrinology 150, 3680-3689.
35. Lai, J., Luo, M. C., Chen, Q., Ma, S., Gardell, L. R., Ossipov, M. H., and Porreca, F. (2006). Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat. Neurosci. 9, 1534-1540.
36. Lau, C. G., and Zukin, R. S. (2007). NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 8, 413-426.
37. Laughlin, T. M., Larson, A. A., and Wilcox, G. L. (2001). Mechanisms of induction of persistent nociception by dynorphin. J. Pharmacol. Exp. Ther. 299, 6-11.
38. Laughlin, T. M., Vanderah, T. W., Lashbrook, J., Nichols, M. L., Ossipov, M., Porreca, F., and Wilcox, G. L. (1997). Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 72, 253-260.
39. Levi, R., Hultling, C., and Seiger, A. (1995). The Stockholm spinal cord injury study. 3. Health-related issues of the Swedish annual level-of-living survey in SCI subjects and controls. Paraplegia 33, 726-730.
40. Lin, J. Y., Cheng, Y. C., Chen, J. Y., Chien, C. C., Lin, S. C., Wen, Y. R., Tsou, T. S., and Ling, Q. D. (2010). Increased spinal prodynorphin gene expression in reinflammation-associated hyperalgesia after neonatal inflammatory insult. BMC Neurosci. 11, 139. doi:10.1186/1471-2202-11-139
41. Liu, X., Fan, X. L., Zhao, Y., Luo, G. R., Li, X. P., Li, R., and Le, W. D. (2005). Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia. J. Neurosci. Res. 81, 653-665.
42. Long, J. B., Petras, J. M., Mobley, W. C., and Holaday, J. W. (1988). Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function. J. Pharmacol. Exp. Ther. 246, 1167-1174.
43. Malan, T. P., Ossipov, M. H., Gardell, L. R., Ibrahim, M., Bian, D., Lai, J., and Porreca, F. (2000). Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain 86, 185-194.
44. Marvizon, J. C., Chen, W., and Murphy, N. (2009). Enkephalins, dynorphins, and beta-endorphin in the rat dorsal horn: an immunofluorescence colocalization study. J. Comp. Neurol. 517, 51-68.
45. McLaughlin, B. J., Barber, R., Saito, K., Roberts, E., and Wu, J. Y. (1975). Immunocytochemical localization of glutamate decarboxylase in rat spinal cord. J. Comp. Neurol. 164, 305-321.
46. McLaughlin, J. P., Xu, M., Mackie, K., and Chavkin, C. (2003). Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization. J. Biol. Chem. 278, 34631-34640.
47. Millan, M. J., Millan, M. H., Pilcher, C. W., Czlonkowski, A., Herz, A., and Colpaert, F. C. (1985). Spinal cord dynorphin may modulate nociception via a kappa-opioid receptor in chronic arthritic rats. Brain Res. 340, 156-159.
48. Nequin, L. G., Alvarez, J., and Schwartz, N. B. (1979). Measurement of serum steroid and gonadotropin levels and uterine and ovarian variables throughout 4 day and 5 day estrous cycles in the rat. Biol. Reprod. 20, 659-670.
49. Paxinos, G., and Watson, C. (1998). The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press.
50. Perney, T. M., Hirning, L. D., Leeman, S. E., and Miller, R. J. (1986). Multiple calcium channels mediate neurotransmitter release from peripheral neurons. Proc. Natl. Acad. Sci. U.S.A. 83, 6656-6659.
51. Persson, S., Schafer, M. K., Nohr, D., Ekstrom, G., Post, C., Nyberg, F., and Weihe, E. (1994). Spinal prodynorphin gene expression in collagen-induced arthritis: influence of the glucocorticosteroid budesonide. Neuroscience 63, 313-326.
52. Pickar, J. H., MacNeil, T., and Ohleth, K. (2010). SERMs: progress and future perspectives. Maturitas 67, 129-138.
53. Przewlocki, R., Haarmann, I., Nikolarakis, K., Herz, A., and Hollt, V. (1988). Prodynorphin gene expression in spinal cord is enhanced after traumatic injury in the rat. Brain Res. 464, 37-41.
54. Reed, W. R., Chadha, H. K., and Hubscher, C. H. (2009). Effects of 17beta-estradiol on responses of viscerosomatic convergent thalamic neurons in the ovariectomized female rat. J. Neurophysiol. 102, 1062-1074.
55. Ritz, M. F., and Hausmann, O. N. (2008). Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats. Brain Res. 1203, 177-188.
56. Samuel, C. S., Coghlan, J. P., and Bateman, J. F. (1998). Effects of relaxin, pregnancy and parturition on collagen metabolism in the rat pubic symphysis. J. Endocrinol. 159, 117-125.
57. Santmyire, B. R., Venkat, V., Beinder, E., and Baylis, C. (2010). Impact of the estrus cycle and reduction in estrogen levels with aromatase inhibition, on renal function and nitric oxide activity in female rats. Steroids 75, 1011-1015.
58. Sayed, Y.,and Taxel, P. (2003). The use of estrogen therapy in men. Curr. Opin. Pharmacol. 3, 650-654.
59. Scheff, S. W., Rabchevsky, A. G., Fugaccia, I., Main, J. A., and Lumpp, J. E. Jr. (2003). Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 20, 179-193.
60. Sharma, H. S., Nyberg, F., and Olsson, Y. (1992). Dynorphin A content in the rat brain and spinal cord after a localized trauma to the spinal cord and its modification with p-chlorophenylalanine. An experimental study using radioimmunoassay technique. Neurosci. Res. 14, 195-203.
61. Siddall, P. J., Xu, C. L., Floyd, N., and Keay, K. A. (1999). C-fos expression in the spinal cord of rats exhibiting allodynia following contusive spinal cord injury. Brain Res. 851, 281-286.
62. Siegel, S., and Castellano, J. Jr. (1988). Nonparametric Statistics for the Behavioral Sciences. Boston: McGraw-Hill.
63. Skilling, S. R., Sun, X., Kurtz, H. J., and Larson, A. A. (1992). Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity. Brain Res. 575, 272-278.
64. Spampinato, S., Canossa, M., Campana, G., Carboni, L., and Bachetti, T. (1995). Estrogen regulation of prodynorphin gene expression in the rat adenohypophysis: effect of the antiestrogen tamoxifen. Endocrinology 136, 1589-1594.
65. Sribnick, E. A., Matzelle, D. D., Ray, S. K., and Banik, N. L. (2006). Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. J. Neurosci. Res. 84, 1064-1075.
66. Tachibana, T., Miki, K., Fukuoka, T., Arakawa, A., Taniguchi, M., Maruo, S., and Noguchi, K. (1998). Dynorphin mRNA expression in dorsal horn neurons after traumatic spinal cord injury: temporal and spatial analysis using in situ hybridization. J. Neurotrauma 15, 485-494.
67. Tang, Q., Lynch, R. M., Porreca, F., and Lai, J. (2000). Dynorphin A elicits an increase in intracellular calcium in cultured neurons via a nonopioid, non-NMDA mechanism. J. Neurophysiol. 83, 2610-2615.
68. Todd, A. J. (2002). Anatomy of primary afferents and projection neurones in the rat spinal dorsal horn with particular emphasis on substance P and the neurokinin 1 receptor. Exp. Physiol. 87, 245-249.
69. Vaeroy, H., Nyberg, F., and Terenius, L. (1991). No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg6-Phe7. Pain 46, 139-143.
70. Vanderah, T. W., Laughlin, T., Lashbrook, J. M., Nichols, M. L., Wilcox, G. L., Ossipov, M. H., Malan, T. P. Jr., and Porreca, F.(1996). Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 68, 275-281.
71. Wang, Z., Gardell, L. R., Ossipov, M. H., Vanderah, T. W., Brennan, M. B., Hochgeschwender, U., Hruby, V. J., Malan, T. P. Jr., Lai, J., and Porreca, F.(2001). Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J. Neurosci. 21, 1779-1786.
72. Waxman, J., and Zatzkis, S. M. (1986). Fibromyalgia and menopause. Examination of the relationship. Postgrad. Med. 80, 165-167, 70-71.
73. Weaver, C. E. Jr., Park-Chung, M., Gibbs, T. T., and Farb, D. H. (1997). 17betaEstradiol protects against NMDAinduced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 761, 338-341.
74. Webb, A. A., Chan, C. B., Brown, A., and Saleh, T. M. (2006). Estrogen reduces the severity of autonomic dysfunction in spinal cord-injured male mice. Behav. Brain Res. 171, 338-349.
75. Widerstrom-Noga, E. G., FelipeCuervo, E., Broton, J. G., Duncan, R. C., and Yezierski, R. P. (1999). Perceived difficulty in dealing with consequences of spinal cord injury. Arch. Phys. Med. Rehabil. 80, 580-586.
76. Woods, A. S., Kaminski, R., Oz, M., Wang, Y., Hauser, K., Goody, R., Wang, H. Y., Jackson, S. N., Zeitz, P., Zeitz, K. P., Zolkowska, D., Schepers, R., Nold, M., Danielson, J., Gräslund, A., Vukojevic, V., Bakalkin, G., Basbaum, A., and Shippenberg, T. (2006). Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity. J. Proteome Res. 5, 1017-1023.
77. Yune, T. Y., Kim, S. J., Lee, S. M., Lee, Y. K., Oh, Y. J., Kim, Y. C., Markelonis, G. J., and Oh, T. H. (2004). Systemic administration of 17beta-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 21, 293-306.
78. Zhang, R. X., Ruda, M. A., and Qiao, J. T. (1998). Pre-emptive intrathecal Mk801, a non-competitive N-methylD-aspartate receptor antagonist, inhibits the up-regulation of spinal dynorphin mRNA and hyperalgesia in a rat model of chronic inflammation. Neurosci. Lett. 241, 57-60.